Stock Movers

On this episode of Stock Movers:

- Johnson & Johnson (JNJ) shares drop as much as 3.1% in premarket trading after the health-care company reported mixed drug sales for the fourth quarter. The firm also forecasted sales for 2026 that beat the average analyst estimate.

- Nathan's Famous (NATH) surged after Smithfield Foods said it would acquire the legendary hot dog brand in a deal valued at about $450 million, securing the rights to a key product in its business’s largest segment.

- Kraft Heinz (KHC) shares closed down 1.36% after the packaged food company registered more than 325 million common shares held by Berkshire Hathaway, its largest shareholder, for potential sale
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Moderna (MRNA) shares jumped on Wednesday on continued momentum after the company’s Tuesday update revealing the long‑term results from a cancer therapy study.

- Nathan's Famous (NATH) surged after Smithfield Foods said it would acquire the legendary hot dog brand in a deal valued at about $450 million, securing the rights to a key product in its business’s largest segment..
- Kraft Heinz shares closed down 1.36% after the packaged food company registered more than 325 million common shares held by Berkshire Hathaway, its largest shareholder, for potential sale.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

-Netflix (NFLX) gave a disappointing forecast for earnings in the months ahead as it spends more on programming and works to close its $82.7 billion deal with Warner Bros. Discovery Inc.

-Charles Schwab (SCHW) reported a surge in average daily trading volume in the fourth quarter as retail investors sought to take advantage of the end of a strong year for the stock market.

-United Airlines (UAL) beat Wall Street estimates for the fourth quarter and anticipates a strong 2026, driven by demand from high-spending domestic passengers and international travelers.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Netflix (NFLX) shares fall after the streaming giant forecast first-quarter earnings below the average analyst estimate. The company also plans to pause its share buybacks in an effort to accumulate cash to fund the pending acquisition of Warner Bros.
- Johnson & Johnson’s (JNJ) fourth-quarter sales beat expectations, led by strong growth for several newer cancer treatments, while issuing higher-than-expected 2026 guidance despite a recent deal with the White House to give discounts on some of the company’s key drugs. Sales are projected to be in a range of between $100 billion and $101 billion this year — above the average of analyst estimates. The company sees adjusted earnings of as much as $11.63 a share for the year. J&J said fourth-quarter earnings of $2.46 a share excluding certain items were reduced by 10 cents due to the company’s $3.05 billion deal to buy Halda Therapeutics.
- United Airlines Holdings (UAL) beat Wall Street estimates for the fourth quarter and anticipates a strong 2026, driven by demand from high-spending domestic passengers and international travelers.United’s upbeat outlook for demand echoes predictions by Delta Air Lines Inc., though both carriers offered a more cautious view for 2026 after the US aviation industry emerged from a volatile year.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Burberry’s sales advanced over the key holiday period as shoppers snapped up the British brand’s tartan scarves and trench coats, especially in China, bolstering hopes of a luxury rebound. The company rose as much as 6.6% in early London trading on Wednesday, the most intraday since November.
- Barry Callebaut appointed former Unilever boss Hein Schumacher to succeed Peter Feld as chief executive officer, as the world’s biggest bulk chocolate maker grapples with the fallout from record cocoa prices. Barry Callebaut rose as much as 7.9% in Zurich trading.
- Danone fell as much as 12% before trimming the decline. Traders point to broker commentary around an announcement by the Singapore Food Agency recalling additional infant formula products.
See omnystudio.com/listener for privacy information.